MASSDEVICE ON CALL — Minnesota life sciences investment took a sharp upward turn in 2013, with total funding more than 80% higher than it had been in 2012.
Medtech accounted for the vast majority of that funding, taking $300 million of the $341 million investment dollars reported for the year, according to an analysis issued by LifeScience Alley.